NCYT vs. IUG, BELL, CREO, EKF, SAR, TRX, VLG, AREC, ETX, and AGL
Should you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include Intelligent Ultrasound Group (IUG), Belluscura (BELL), Creo Medical Group (CREO), EKF Diagnostics (EKF), Sareum (SAR), Tissue Regenix Group (TRX), Venture Life Group (VLG), Arecor Therapeutics (AREC), e-therapeutics (ETX), and ANGLE (AGL). These companies are all part of the "medical" sector.
Intelligent Ultrasound Group (LON:IUG) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, community ranking, dividends, analyst recommendations, profitability, earnings and valuation.
In the previous week, Novacyt's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.
Intelligent Ultrasound Group has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.8, suggesting that its stock price is 280% less volatile than the S&P 500.
Novacyt has a net margin of 0.00% compared to Novacyt's net margin of -23.11%. Intelligent Ultrasound Group's return on equity of -21.08% beat Novacyt's return on equity.
Novacyt received 36 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.
Intelligent Ultrasound Group has higher revenue and earnings than Novacyt. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.
76.9% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 13.4% of Intelligent Ultrasound Group shares are held by company insiders. Comparatively, 3.2% of Novacyt shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Intelligent Ultrasound Group and Novacyt tied by winning 6 of the 12 factors compared between the two stocks.
Get Novacyt News Delivered to You Automatically
Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NCYT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
